- Home
- Hematology
Hematology
Idiopathic Thrombocytopenic Purpura CME: The France Foundation: ITP Community Case Exchange Series: 2008- Emerging Management Strategies for ITP: St Louis, MO: September 25, 2008
- By Idiopathic Thrombocytopenic Purpura (ITP)
- Published Today
- Oncology , Hepatology , Hematology
- Unrated
ITP Community Case Exchange Series: 2008- Emerging Management Strategies for ITP
The France Foundation
September 25, 2008
This interactive CME activity will begin with a lecture by an ITP expert titled "2008-Emerging Management Strategies for ITP". After questions are addressed, learners will have the opportunity to share and discuss their own patient cases with the expert and their peers participating in this activity.
The France Foundation
September 25, 2008
This interactive CME activity will begin with a lecture by an ITP expert titled "2008-Emerging Management Strategies for ITP". After questions are addressed, learners will have the opportunity to share and discuss their own patient cases with the expert and their peers participating in this activity.
Continuing Medical Education: Internal Medicine CME: Continuing Education Inc.: Update in Medicine: Gastroenterology and Hematology/Oncology: Cruise Conference CME: February 15 - 22, 2009
- By Continuing Education, Inc.
- Published 08/29/2008
- Oncology , Internal Medicine , Hematology , Gastroenterology
- Unrated
Update in Medicine: Gastroenterology and Hematology/Oncology
Continuing Education Inc.
February 15 - 22, 2009
7-Night Southern Caribbean Conference from San Juan, Puerto Rico
Continuing Education Inc.
February 15 - 22, 2009
7-Night Southern Caribbean Conference from San Juan, Puerto Rico
Continuing Medical Education: Biochemistry CME: University of California, San Diego--School of Medicine:Mass Spectrometry: Applications to the Clinical Laboratory 2008: San Diego, CA: Course CME: November 1-5, 2008
- By University of California, San Diego - School of Medicine
- Published 07/30/2008
- Quality Assurance , Immunology , Hematology , Biochemistry
- Unrated
Mass Spectrometry: Applications to the Clinical Laboratory 2008
University of California, San Diego--School of Medicine
November 1-5, 2008
Mass Spectrometry: Applications to the Clinical Laboratory 2008 (MSACL '08) has been developed to provide scientists in the clinical laboratory a forum for in-depth and informal discussions of the most recent developments in the practical application of mass spectrometry to analyses previously done by various other technologies such as immunoassays. While these immunoassay methods have been successful for the last 50 years, mass spectrometry methods are now providing these analytical results in a better, faster and less expensive fashion. Innovative mass spectrometry technologies, alone and combined with molecular methods have lead to improved diagnostic testing approaches. At this time large reference laboratories and major medical centers have demonstrated that this approach leads to more accurate testing which results in improved patient care and reduced costs. This conference will focus on the practical applications of mass spectrometry to the clinical chemistry/toxicology, microbiology/virology, proteomic, metabolomic and tissue histology laboratories. In addition to the current technologies, issues of regulation, standardization, validation and quality control will be addressed.
University of California, San Diego--School of Medicine
November 1-5, 2008
Mass Spectrometry: Applications to the Clinical Laboratory 2008 (MSACL '08) has been developed to provide scientists in the clinical laboratory a forum for in-depth and informal discussions of the most recent developments in the practical application of mass spectrometry to analyses previously done by various other technologies such as immunoassays. While these immunoassay methods have been successful for the last 50 years, mass spectrometry methods are now providing these analytical results in a better, faster and less expensive fashion. Innovative mass spectrometry technologies, alone and combined with molecular methods have lead to improved diagnostic testing approaches. At this time large reference laboratories and major medical centers have demonstrated that this approach leads to more accurate testing which results in improved patient care and reduced costs. This conference will focus on the practical applications of mass spectrometry to the clinical chemistry/toxicology, microbiology/virology, proteomic, metabolomic and tissue histology laboratories. In addition to the current technologies, issues of regulation, standardization, validation and quality control will be addressed.
Continuing Medical Education: HEMATOLOGY CME: 16TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA).: June 09-12, 2011
- By EHA Executive Office
- Published 06/22/2008
- Hematology
- Unrated
16TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA).
June 09-12, 2011
June 09-12, 2011
The Latest News Feeds in Hematology
The growing development of multimodality imaging in oncology. (Sep 5, 2008 10:23) Related Articles The growing development of multimodality imaging in oncology. Crit Rev Oncol Hemat..
Re: wittig a. et al, boron analysis and boron imaging in biological materials for boron neutron capture therapy (bnct), crit. rev. oncol./hematol. (2008), doi:10.101016/j.critrevonc.2008.03.004 (this issue). (Sep 5, 2008 10:23)
Related Articles RE: Wittig A. et al, Boron analysis and boron imaging in biological materials for ..
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in rat. (Sep 5, 2008 06:49)
Related Articles Temporal gene expression profiling indicates early up-regulation of interleukin-6 ..
2008 breast cancer symposium (bcs) (Sep 5, 2008 01:05)
Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Onco..
Asco breast: her2 conversion linked to incomplete response to trastuzumab (herceptin) (Sep 4, 2008 15:09)
WASHINGTON (MedPage Today) -- Almost a third of incomplete responses to trastuzumab (Herceptin) may ..
Evidence-based surgical care and the evolution of fast-track surgery (Sep 4, 2008 15:00)
The integration of unimodality evidence-based perioperative care principles into a multimodal fast-t..
Prostate irradiation raises long-term risk of colon cancer (Sep 4, 2008 14:48)
Data from the Geneva Cancer Registry show an increased long-term risk of colon cancer after external..
Down syndrome patients have worse all outcomes (Sep 4, 2008 14:40)
Down syndrome patients who develop acute lymphoblastic leukemia (ALL) have worse treatment outcomes ..
Tumor size important indicator for survival in lung cancer (Sep 4, 2008 12:51)
Among patients with resected non-small-cell lung carcinoma, tumors over 15 mm in diameter are associ..
Walter reed evaluation concludes oraquick(r) hcv test is preferred over other rapid tests (Sep 4, 2008 10:00)
OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced..
